The legacy of Viagra and its influence on the pharmaceutical sector presents a challenging question regarding its continued attractiveness as an investment. Initially a blockbuster success, generating huge sums , generic competition has considerably eroded profit margins . While leading pharmaceutical firms hold patents on related therapies and inv

The trajectory of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in key markets has Adult introduced considerable uncertainty . Investors are now facing the effect of generic co